Search Within

Stephen D Nimer

  1. "Myeloma"
Formats
  1. Meeting Abstract (22)
  2. Journal Article (8)
  3. Book Section (1)
Groups
  1. Center for Hematologic Malignancies (31)
  2. Department of Medicine (31)
  3. Hematologic Malignancies, Division of (31)
  4. Myeloma (31)
  5. Survivorship Research (15)
  6. Bone Marrow Transplant (14)

More Groups

People
  1. Hani Hassoun (31)
  2. Raymond Comenzo (22)
  3. Adam Cohen (15)
  4. Lilian Reich (15)
  5. Martin Fleisher (15)
  6. Heather Landau (14)

More People

Years
  1. 2012 (1)
  2. 2011 (1)
  3. 2010 (3)
  4. 2009 (6)
  5. 2008 (5)
  6. 2007 (3)

More Years

Publications
  1. Blood (18)
  2. Amyloid (3)
  3. Bone Marrow Transplantation (2)
  4. British Journal of Haematology (2)
  5. Journal of Clinical Oncology (2)
  6. Clinical Lymphoma and Myeloma (1)

More Publications

Publishers
  1. American Society of Hematology (18)
  2. Taylor & Francis Group (4)
  3. Nature Publishing Group (3)
  4. American Society of Clinical Oncology (2)
  5. John Wiley & Sons (2)
  6. CRC Press/Taylor & Francis Group (1)

More Publishers

Results (31)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • CD32B expression reflects intraclonal functional heterogeity in multiple myeloma
    Meeting Abstract

    Comenzo, R. L.; Jhanwar, S. C.; Nimer, S. D.; Zhou, P.; Boruchov, A.; Lu, P.; Bonvini, E.; Hassoun, H.
    Clinical Lymphoma and Myeloma (2009)

    Fulltext@MSK | Save
  • Risk-adapted melphalan with stem cell transplant (SCT) and adjuvant dexamethasone (dex) +/- thalidomide (thal) achieves low treatment related mortality and high hematologic response rates
    Book Section

    Cohen, A. D.; Zhou, P.; Reich, L.; Hassoun, H.; Teruya-Feldstein, J.; Filippa, D. A.; Clark, B.; Stubblefield, M.; Fleisher, M.; Nimer, S. D.; more...
    In Skinner, M.; Berk, J. L.; Connors, L. H.; Seldin, D. C. (Eds.) XIth International Symposium on Amyloidosis (2008)

    Fulltext@MSK | Save
  • CD32B expression reflects phenotypic and functional heterogeneity in multiple myeloma (MM)
    Meeting Abstract

    Zhou, P.; Boruchov, A. M.; Hoffman, J. E.; Mo, Q. X.; Olshen, A.; Glasner, E.; Bonvini, E.; Koenig, S.; Drieghe, E.; Fleisher, M.; more...
    Blood (2008)

    Fulltext@MSK | Save
  • Sequential administration of bortezomib, liposomal doxorubicin and dexamethasone (BDD) followed by thalidomide and dexamethasone (TD) results in rapid control of untreated high-risk multiple myeloma (MM) and improves depth of response
    Meeting Abstract

    Landau, H.; Hassoun, H.; Cohen, A.; Hoover, E.; Kewalramani, T.; Boruchov, A.; Klimek, V.; Reich, L.; Riedel, E.; Pandit-Taskar, N.; more...
    Blood (2008)

    Fulltext@MSK | Save
  • Early adjuvant treatment after risk-adapted autologous stem cell transplant for systemic light-chain amyloidosis: Increased hospitalizations and impaired immune recovery but improved responses and overall survival
    Meeting Abstract

    Hoffman, J. E.; Hassoun, H.; Landau, H.; Hoover, E.; Cohen, A.; Nimer, S.; Comenzo, R.
    Blood (2008)

    Fulltext@MSK | Save
  • High-dose melphalan and auto-SCT in patients with monoclonal Ig deposition disease
    Journal Article

    Hassoun, H.; Flombaum, C.; D'Agati, V. D.; Rafferty, B. T.; Cohen, A.; Klimek, V. M.; Boruchov, A.; Kewalramani, T.; Reich, L.; Nimer, S. D.; more...
    Bone Marrow Transplantation (2008)

    Fulltext@MSK | Save
  • High dose chemotherapy and autologous stem cell transplantation with melphalan in patients with monoclonal immunoglobulin deposition disease associated with multiple myeloma
    Meeting Abstract

    Hassoun, H.; Rafferty, B. T.; Flombaum, C.; D'Agati, V. D.; Klimek, V. M.; Cohen, A.; Boruchov, A.; Kewalramani, T.; Reich, L.; Landau, H.; more...
    Blood (2007)

    Fulltext@MSK | Save
  • Predictors of survival in de novo cardiac amyloidosis
    Meeting Abstract

    Comenzo, R. L.; Maurer, M.; Cohen, A.; Hassoun, H.; Zhou, P.; Lu, P.; Fleisher, M.; Lebovic, D.; Feldstein, J.; Steingart, R.; more...
    Blood (2007)

    Fulltext@MSK | Save
  • Risk-adapted autologous stem cell transplantation with adjuvant dexamethasone ± thalidomide for systemic light-chain amyloidosis: Results of a phase II trial
    Journal Article

    Cohen, A. D.; Zhou, P.; Chou, J.; Teruya-Feldstein, J.; Reich, L.; Hassoun, H.; Levine, B.; Filippa, D. A.; Riedel, E.; Kewalramani, T.; more...
    British Journal of Haematology (2007)

    Fulltext@MSK | Save
  • Mobilization of blood stem cells with G-CSF in systemic light-chain amyloidosis: Dominant organ involvement significantly affects stem cell collection
    Meeting Abstract

    Comenzo, R.; Hassoun, H.; Reich, L.; Collins, N.; Nuta, A.; Chen, X. S.; Zhou, P.; Clark, B.; Teruya-Feldstein, J.; Fleisher, M.; more...
    Blood (2006)

    Fulltext@MSK | Save